Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I PK and Safety Study of LPI 001 in Japanese and Caucasian Women
jRCT2051200154Phase 1Completed
- Sponsor
- Linepharma International
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of mifepristone in None, sponsored by Linepharma International. Primary endpoints: Pharmacokinetics of LPI 001 and Safety and tolerability of LPI 001. Started Mar 2021; status: completed.
02
Drugs
mifepristone
Beyond the preview
Go deeper on jRCT2051200154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051200154.